Financial News
Latest News about PFE
Recent news which mentions PFE
Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200
October 31, 2023
From Benzinga
From Motley Fool
Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results
October 31, 2023
From Benzinga
US Stocks Fall; Pfizer Swings To Q3 Loss
October 31, 2023
From Benzinga
From MarketWatch
Pfizer Q3 Earnings: Drugmaker Swings To Quarterly Loss On COVID-19 Write-Offs, Sales Fall 42%
October 31, 2023
Tickers
PFE
From Benzinga
U.S. Stocks Poised To Extend Gains As Fed Meeting Gets Underway; Why This Analyst Expects 'Young Bull Market' To Remain Alive
October 31, 2023
From Benzinga
Charlie Munger says not much ‘low-hanging fruit left’ as he discusses Apple, Costco vs. Walmart and EVs.
October 31, 2023
From MarketWatch
Earnings Scheduled For October 31, 2023
October 31, 2023
From Benzinga
3 No-Brainer Stocks to Buy With $50 Right Now
October 31, 2023
From Motley Fool
S&P 500 futures steady as lower Treasury yields support sentiment
October 31, 2023
From MarketWatch
From Benzinga
Pfizer, AMD And 3 Stocks To Watch Heading Into Tuesday
October 31, 2023
From Benzinga
7 Low-Risk Stock Picks to Double Your Money
October 30, 2023
From InvestorPlace
Monday's Market Minute: Fed In Focus This Week, But Plenty Of Earnings & Data As Well
October 30, 2023
From Benzinga
GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
October 30, 2023
From Benzinga
The market’s in a funk. Why now is an attractive entry point for long-term investors, says JPMorgan strategist.
October 30, 2023
From MarketWatch
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
From Benzinga
The 7 Most Undervalued Long-Term Stocks to Buy: October 2023
October 29, 2023
From InvestorPlace
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
From Motley Fool
Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets
October 27, 2023
From Benzinga
From InvestorPlace
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
October 27, 2023
From Benzinga
SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff
October 27, 2023
From InvestorPlace
The 7 Most Undervalued Dividend Stocks to Buy: October 2023
October 27, 2023
From InvestorPlace
7 Undervalued Stocks That Analysts Love Right Now
October 26, 2023
From InvestorPlace
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.